Retacrit Drug Interactions: What to Avoid and What to Tell Your Doctor

Before starting Retacrit (epoetin alfa-epbx), it's important that your prescriber knows every medication, supplement, and vitamin you take. While Retacrit has fewer direct drug-drug interactions than many medications, certain combinations significantly increase your risk of serious side effects — particularly blood clots, high blood pressure, and cardiovascular events.

Most Important Interactions: Thalidomide and Its Derivatives

The most clinically significant Retacrit interactions involve thalidomide-class drugs used in multiple myeloma and other blood cancers:

• Lenalidomide (Revlimid): Combining lenalidomide with ESAs like Retacrit significantly increases the risk of venous thromboembolism (blood clots). Patients on lenalidomide are already at elevated thrombosis risk, and adding an ESA amplifies this. If used together, anticoagulation therapy (blood thinners) is typically required.
• Thalidomide: Similar to lenalidomide, thalidomide plus ESAs increases DVT/PE risk. Blood clot prevention measures are essential.
• Pomalidomide (Pomalyst): Another thalidomide analog with similar thrombosis-amplifying effects when combined with ESAs.

If you are taking any of these medications, your oncologist and hematologist must carefully weigh the risks and benefits before prescribing Retacrit. Prophylactic anticoagulation (typically low-molecular-weight heparin or aspirin) is usually required.

Blood Pressure Medications (Antihypertensives)

Retacrit commonly raises blood pressure, particularly in the early weeks of treatment. Approximately 25% of dialysis patients require initiation of or increases in antihypertensive therapy after starting Retacrit. This creates a two-way interaction:

• Retacrit may require you to start or increase antihypertensive medication — meaning more drugs on your list
• As your anemia improves with Retacrit, your existing blood pressure medications may need dose adjustments

Tell your prescriber about all blood pressure medications you take, including beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and diuretics.

Iron Supplements and IV Iron

Iron is not an "interaction" in the negative sense — it's actually required for Retacrit to work. As Retacrit stimulates rapid red blood cell production, iron demand surges. Without adequate iron (ferritin ≥100 ng/mL, TSAT ≥20%), Retacrit will be less effective.

Most patients on Retacrit are also prescribed iron supplementation (oral or IV). This is an intentional therapeutic combination, not a harmful interaction.

Androgens (Testosterone and Related Drugs)

Androgens (testosterone-based medications or anabolic steroids) can enhance the erythropoietic effect of Retacrit. This is generally not a clinically dangerous interaction, but it can cause hemoglobin to rise more rapidly or to a higher level than intended — potentially triggering cardiovascular risk. Monitor hemoglobin more closely if a patient is on androgen therapy.

Chemotherapy Drugs

Retacrit is often used alongside myelosuppressive chemotherapy agents to combat chemotherapy-induced anemia. However, important restrictions apply to its use with specific chemotherapy protocols:

• Retacrit should NOT be used in cancer patients receiving treatment with curative intent — ESAs have been shown to increase tumor progression in some cancer types when used in this setting
• It should NOT be used with hormonal agents, biologic therapies, or radiotherapy unless myelosuppressive chemotherapy is also being given concurrently

Cyclosporine

There are reports that as anemia is corrected with ESAs, blood levels of cyclosporine (an immunosuppressant used in transplant patients) may change due to altered protein binding from higher hematocrit. If you are a transplant patient on cyclosporine and starting Retacrit, your cyclosporine levels should be monitored carefully.

What to Tell Your Doctor Before Starting Retacrit

Before starting Retacrit, give your prescriber a complete medication list including:

• All prescription medications (especially blood thinners, blood pressure drugs, cancer drugs)
• Over-the-counter medications (aspirin, NSAIDs, antacids)
• Vitamins and supplements (especially iron, B12, folate, vitamin C)
• Herbal products
• History of blood clots, high blood pressure, or cardiovascular disease
• Pregnancy or breastfeeding status (multi-dose vials contain benzyl alcohol which is contraindicated)

The Bottom Line

The most clinically significant Retacrit interactions involve thalidomide/lenalidomide (dramatically increased clot risk), antihypertensives (blood pressure management changes), and cyclosporine (level monitoring needed). Always disclose your full medication list to every prescriber involved in your care. For more on Retacrit risks, read our guide to Retacrit side effects. And if you need help finding Retacrit in stock, medfinder is here to help.